Processa Pharmaceuticals Inc (PCSA)
1.97
-0.05
(-2.48%)
USD |
NASDAQ |
May 16, 16:00
2.02
+0.05
(+2.54%)
After-Hours: 20:00
Processa Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2015 | -233.1% |
September 30, 2015 | 26.73% |
June 30, 2015 | |
March 31, 2015 | 33.88% |
December 31, 2014 | 51.90% |
September 30, 2014 | 51.94% |
June 30, 2014 | 37.79% |
March 31, 2014 | 55.08% |
Date | Value |
---|---|
December 31, 2013 | 51.63% |
September 30, 2013 | 36.11% |
June 30, 2013 | 36.75% |
March 31, 2013 | 36.85% |
December 31, 2012 | -5.26% |
September 30, 2012 | 30.87% |
June 30, 2012 | 44.52% |
March 31, 2012 | 15.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
DIH Holding US Inc | -- |
NovaBay Pharmaceuticals Inc | 68.19% |
Palatin Technologies Inc | 95.20% |
iBio Inc | -- |
Theriva Biologics Inc | -- |